Influence of protein, red blood cell count, and surgical site on shunt performance following aneurysmal subarachnoid hemorrhage.
Sandberg
David I
DI
Heros
Roberto C
RC
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology; D002552:Cerebral Ventricles / Q000473:pathology / Q000601:surgery*; D002555:Cerebrospinal Fluid / Q000378:metabolism; D004906:Erythrocyte Count; D006801:Humans; D007427:Intracranial Pressure / Q000502:physiology; D011506:Proteins / Q000378:metabolism*; D012307:Risk Factors; D013345:Subarachnoid Hemorrhage / Q000097:blood* / Q000473:pathology / Q000601:surgery*; D016896:Treatment Outcome; D017287:Ventriculoperitoneal Shunt / Q000009:adverse effects / Q000379:methods*
D000900:Anti-Bacterial Agents; D011506:Proteins